Literature DB >> 33686443

Role of B-cells in Mycosis Fungoides.

Pia Rude Nielsen1, Jens Ole Eriksen, Mia Dahl Sørensen, Ulrike Wehkamp, Lise M Lindahl, Michael Bzorek, Lars Iversen, Anders Woetman, Niels Ødum, Thomas Litman, Lise Mette Rahbek Gjerdrum.   

Abstract

Mycosis fungoides is the most common type of cutaneous T-cell lymphoma. The inflammatory micro-environment in mycosis fungoides is complex. There is accumulating evidence that the neoplastic T-cells take control of the microenvironment and thereby promote their own expansion by suppressing cellular immunity. B-cells have proved to be upregulated in large-cell transformed mycosis fungoides, and could potentially play a role in disease progression. To investigate the presence of B-cells in mycosis fungoides compared with controls, this study analysed 85 formalin-fixed and paraffin-embedded mycosis fungoides biopsies. MS4A1 gene expression was significantly upregulated in mycosis fungoides compared with controls (p < 0.0001) and further upregulated in disease progression, (p = 0.001). Digital quantification of PAX5+/CD20+ cells confirmed the increased presence of B-cells in mycosis fungoides compared with controls. No co-labelling of CD3/CD20 was observed in the neoplastic T-cells. This study found a significantly increased presence of B-cells in the tumour-associated microenvironment in mycosis fungoides. These findings could potentially lead to new treatment strategies for mycosis fungoides.

Entities:  

Keywords:  cutaneous T-cell lymphoma; mycosis fungoides; tumour microenvironment; B-cells

Mesh:

Substances:

Year:  2021        PMID: 33686443      PMCID: PMC9366504          DOI: 10.2340/00015555-3775

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  40 in total

1.  Use of commercially available rabbit monoclonal antibodies for immunofluorescence double staining.

Authors:  Michael Bzorek; Inger Merete Stamp; Bodil Laub Petersen; Lisbeth Frederiksen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2008-07

2.  Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides.

Authors:  Taro Akatsuka; Tomomitsu Miyagaki; Rina Nakajima; Hiroaki Kamijo; Tomonori Oka; Naomi Takahashi; Hiraku Suga; Ayumi Yoshizaki; Yoshihide Asano; Makoto Sugaya; Shinichi Sato
Journal:  Eur J Dermatol       Date:  2018-06-01       Impact factor: 3.328

3.  Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma.

Authors:  Sebastian Theurich; Max Schlaak; Harold Steguweit; Lukas C Heukamp; Kerstin Wennhold; Peter Kurschat; Anja Rabenhorst; Karin Hartmann; Hans Schlösser; Alexander Shimabukuro-Vornhagen; Udo Holtick; Michael Hallek; Rudolf Stadler; Michael von Bergwelt-Baildon
Journal:  J Clin Oncol       Date:  2014-10-27       Impact factor: 44.544

Review 4.  The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.

Authors:  Rein Willemze; Lorenzo Cerroni; Werner Kempf; Emilio Berti; Fabio Facchetti; Steven H Swerdlow; Elaine S Jaffe
Journal:  Blood       Date:  2019-01-11       Impact factor: 22.113

5.  Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma.

Authors:  Lise M Lindahl; Andreas Willerslev-Olsen; Lise M R Gjerdrum; Pia R Nielsen; Edda Blümel; Anne H Rittig; Pamela Celis; Bjorn Herpers; Jürgen C Becker; Birgitte Stausbøl-Grøn; Mariusz A Wasik; Maria Gluud; Simon Fredholm; Terkild B Buus; Claus Johansen; Claudia Nastasi; Lukas Peiffer; Linda Kubat; Michael Bzorek; Jens O Eriksen; Thorbjørn Krejsgaard; Charlotte M Bonefeld; Carsten Geisler; Tomas Mustelin; Erik Langhoff; Michael Givskov; Anders Woetmann; Mogens Kilian; Thomas Litman; Lars Iversen; Niels Odum
Journal:  Blood       Date:  2019-07-22       Impact factor: 22.113

Review 6.  Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.

Authors:  Tomomitsu Miyagaki; Manabu Fujimoto; Shinichi Sato
Journal:  Int Immunol       Date:  2015-05-08       Impact factor: 4.823

Review 7.  Immunological milieu in mycosis fungoides and Sézary syndrome.

Authors:  Tomomitsu Miyagaki; Makoto Sugaya
Journal:  J Dermatol       Date:  2014-01       Impact factor: 4.005

8.  Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.

Authors:  Thorbjørn Krejsgaard; Claudia S Vetter-Kauczok; Anders Woetmann; Hermann Kneitz; Karsten W Eriksen; Paola Lovato; Qian Zhang; Mariusz A Wasik; Carsten Geisler; Elisabeth Ralfkiaer; Juergen C Becker; Niels Ødum
Journal:  Blood       Date:  2009-04-07       Impact factor: 22.113

9.  Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis.

Authors:  Tali Czarnowicki; Juana Gonzalez; Kathleen M Bonifacio; Avner Shemer; Peng Xiangyu; Norma Kunjravia; Dana Malajian; Judilyn Fuentes-Duculan; Hitokazu Esaki; Shinji Noda; Yeriel Estrada; Hui Xu; Xiuzhong Zheng; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2015-10-05       Impact factor: 10.793

10.  Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.

Authors:  Nina A Sibbesen; Katharina L Kopp; Ivan V Litvinov; Lars Jønson; Andreas Willerslev-Olsen; Simon Fredholm; David L Petersen; Claudia Nastasi; Thorbjørn Krejsgaard; Lise M Lindahl; Robert Gniadecki; Nigel P Mongan; Denis Sasseville; Mariusz A Wasik; Lars Iversen; Charlotte M Bonefeld; Carsten Geisler; Anders Woetmann; Niels Odum
Journal:  Oncotarget       Date:  2015-08-21
View more
  2 in total

1.  Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma.

Authors:  Xiangjun Liu; Shanzhao Jin; Simeng Hu; Ruoyan Li; Haihao Pan; Yi Liu; Pan Lai; Deshu Xu; Jingru Sun; Ziyang Liu; Yumei Gao; Yifan Zhao; Fengjie Liu; Yu Xiao; Yingyi Li; Yujie Wen; Zhuojing Chen; Bufang Xu; Yuchieh Lin; Menglong Ran; Qianxi Li; Shuxia Yang; Hang Li; Ping Tu; Muzlifah Haniffa; Sarah A Teichmann; Fan Bai; Yang Wang
Journal:  Nat Commun       Date:  2022-03-03       Impact factor: 17.694

2.  Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma.

Authors:  Matthias Farlik; Patrick M Brunner; Katharina Rindler; Constanze Jonak; Natalia Alkon; Felix M Thaler; Harald Kurz; Lisa E Shaw; Georg Stingl; Wolfgang Weninger; Florian Halbritter; Wolfgang M Bauer
Journal:  Mol Cancer       Date:  2021-09-28       Impact factor: 27.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.